Global Point Of Care Diagnostics Market, 2016 – 2022

Point Of Care Diagnostics Market
Based on the end-user, the market can be segmented into hospitals, clinics, and ambulatory
care settings. Clinic segment was the leading segment and it accounted for the large chunk of
market share in 2016. Increasing adoption of these tests in the clinics for diagnosis of several
infections and monitoring of disease progression by assessment of symptoms and other
parameters is expected to boost the demand for POCT in this segment. Home health care is
another important segment of this segment.
The global point of care market was dominated by North America with over 42% share of the
total market in 2016. This growth is mainly due to increased prevalence of diseases in the
region and presence of favorable government regulations and initiatives pertaining to the
development of healthcare infrastructure. Asia Pacific is another important regional market and
is expected to show witness fastest growth in the near future. This can be attributed to the
presence of high unmet medical needs and technological advancement in healthcare
infrastructure, growing medical awareness, and rise in per capita income levels in developing
economies of including India and China.
Some of the key players in the market such as Roche Diagnostics, Alere Inc ., Danaher
Corporation, Abbott Laboratories, Johnson and Johnson, Instrumentation Laboratory, Trinity
Biotech PLC, OraSure Technologies Inc, bioMerieux, Qiagen N.V. and Siemens Healthcare.
Browse the full “Point Of Care Diagnostics Market by Products, by Prescription Mode
(Prescription-Based Testing Kits and Over-the-Counter Testing Kits) Market for
Hospitals, Clinics and Ambulatory Care Settings: Global Industry Perspective,
Comprehensive Analysis, and Forecast, 2016 – 2022” report
at https://www.zionmarketresearch.com/report/point-of-care-diagnostics-market